ArticleClinical and experimental hepatology2018

Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients.

Adel Abdel-Moneim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.